Tessa Adams1, Elaine Wan2, Ying Wei3, Romina Wahab1, Francesco Castagna1, Gang Wang1, Memet Emin1, Cesare Russo2, Shunichi Homma2, Thierry H Le Jemtel4, Sanja Jelic1. 1. Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, NY. 2. Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, NY. 3. Division of Biostatistics, Columbia University College of Physicians and Surgeons, New York, NY. 4. Section of Cardiology, Tulane University School of Medicine, New Orleans, LA.
Abstract
BACKGROUND: The relative risk for cardiovascular diseases in passive smokers is similar to that of active smokers despite almost a 100-fold lower dose of inhaled cigarette smoke. However, the mechanisms underlying the surprising susceptibility of the vascular tissue to the toxins in secondhand smoke (SHS) have not been directly investigated. The aim of this study was to investigate directly vascular endothelial cell function in passive smokers. METHODS: Using a minimally invasive method of endothelial biopsy, we investigated directly the vascular endothelium in 23 healthy passive smokers, 25 healthy active smokers, and 23 healthy control subjects who had never smoked and had no regular exposure to SHS. Endothelial nitric oxide synthase (eNOS) function (expression of basal eNOS and activated eNOS [phosphorylated eNOS at serine1177 (P-eNOS)]) and expression of markers of inflammation (nuclear factor-κB [NF-κB]) and oxidative stress (nitrotyrosine) were assessed in freshly harvested venous endothelial cells by quantitative immunofluorescence. RESULTS: Expression of eNOS and P-eNOS was similarly reduced and expression of NF-κB was similarly increased in passive and active smokers compared with control subjects. Expression of nitrotyrosine was greater in active smokers than control subjects and similar in passive and active smokers. Brachial artery flow-mediated dilation was similarly reduced in passive and active smokers compared with control subjects, consistent with reduced endothelial NO bioavailability. CONCLUSIONS: Secondhand smoking increases vascular endothelial inflammation and reduces active eNOS to a similar extent as active cigarette smoking, indicating direct toxic effects of SHS on the vasculature.
BACKGROUND: The relative risk for cardiovascular diseases in passive smokers is similar to that of active smokers despite almost a 100-fold lower dose of inhaled cigarette smoke. However, the mechanisms underlying the surprising susceptibility of the vascular tissue to the toxins in secondhand smoke (SHS) have not been directly investigated. The aim of this study was to investigate directly vascular endothelial cell function in passive smokers. METHODS: Using a minimally invasive method of endothelial biopsy, we investigated directly the vascular endothelium in 23 healthy passive smokers, 25 healthy active smokers, and 23 healthy control subjects who had never smoked and had no regular exposure to SHS. Endothelial nitric oxide synthase (eNOS) function (expression of basal eNOS and activated eNOS [phosphorylated eNOS at serine1177 (P-eNOS)]) and expression of markers of inflammation (nuclear factor-κB [NF-κB]) and oxidative stress (nitrotyrosine) were assessed in freshly harvested venous endothelial cells by quantitative immunofluorescence. RESULTS: Expression of eNOS and P-eNOS was similarly reduced and expression of NF-κB was similarly increased in passive and active smokers compared with control subjects. Expression of nitrotyrosine was greater in active smokers than control subjects and similar in passive and active smokers. Brachial artery flow-mediated dilation was similarly reduced in passive and active smokers compared with control subjects, consistent with reduced endothelial NO bioavailability. CONCLUSIONS: Secondhand smoking increases vascular endothelial inflammation and reduces active eNOS to a similar extent as active cigarette smoking, indicating direct toxic effects of SHS on the vasculature.
Authors: Guohao Dai; Saran Vaughn; Yuzhi Zhang; Eric T Wang; Guillermo Garcia-Cardena; Michael A Gimbrone Journal: Circ Res Date: 2007-08-02 Impact factor: 17.367
Authors: J F Argacha; D Fontaine; D Adamopoulos; A Ajose; P van de Borne; J Fontaine; G Berkenboom Journal: J Cardiovasc Pharmacol Date: 2008-09 Impact factor: 3.105
Authors: Heather M Johnson; Linda K Gossett; Megan E Piper; Susan E Aeschlimann; Claudia E Korcarz; Timothy B Baker; Michael C Fiore; James H Stein Journal: J Am Coll Cardiol Date: 2010-03-17 Impact factor: 24.094
Authors: Sanja Jelic; David J Lederer; Tessa Adams; Margherita Padeletti; Paolo C Colombo; Phillip H Factor; Thierry H Le Jemtel Journal: Circulation Date: 2010-02-16 Impact factor: 29.690
Authors: Andreas D Flouris; Giorgos S Metsios; Andres E Carrillo; Athanasios Z Jamurtas; Konstantinos Gourgoulianis; Theodoros Kiropoulos; Manolis N Tzatzarakis; Aristidis M Tsatsakis; Yiannis Koutedakis Journal: Am J Respir Crit Care Med Date: 2009-03-05 Impact factor: 21.405
Authors: S Christy Sadreameli; Benjamin T Kopp; Susan E Creary; Michelle N Eakin; Sharon McGrath-Morrow; John J Strouse Journal: Int J Environ Res Public Health Date: 2016-11-12 Impact factor: 3.390
Authors: Xiaohua Ye; Jingya Huang; Liang Xia; Xiaojun Xu; Xiao Gong; Yanjun Xu Journal: Int J Environ Res Public Health Date: 2019-04-08 Impact factor: 3.390
Authors: Emily Wheeler; Mary Walsh-Wilcox; Meera Shah; Abinash Achrekar; Joe R Anderson; Mary K Walker Journal: Cardiovasc Toxicol Date: 2020-08-25 Impact factor: 3.231
Authors: Jingya Huang; Bin Xu; Dan Guo; Ting Jiang; Wei Huang; Guocong Liu; Xiaohua Ye Journal: Int J Environ Res Public Health Date: 2018-05-14 Impact factor: 3.390
Authors: Sydne I DiGiacomo; Mohammad-Ali Jazayeri; Rajat S Barua; John A Ambrose Journal: Int J Environ Res Public Health Date: 2018-12-31 Impact factor: 3.390